Viridian Therapeutics's total assets for Q4 2024 were $742.40M, a decrease of -3.82% from the previous quarter. VRDN total liabilities were $70.76M for the fiscal quarter, a 9.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.